References
- De Degio Balaguer R, Bacoud-Lévi A-C. Aspects cliniques et neuropsychologiques de la maladie de Huntington [Clinical and neuropsychological aspects of Huntington's disease]. 2015
- Simonin C, Krystkowiak P. Les aspects cliniques de la maladie de Huntington Troubles moteurs, cognitifs et psychiatriques. Neurologies. 2009; 12(114): 17–23.
- Roos RA. Huntington's disease: a clinical review. Orphanet J Rare Dis. 2010; 5: 40.
- Chaulet S. Les determinants suicidaires dans la chorée de Huntington: place de l'environnement [Suicidal determinants in Huntington’s chorea: place of environment]. Psychiatry thesis. 2008
- Carlozzi NE, Tulsky DS. Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. J Health Psychol. 2013; 18(2): 212–25.
- Hocaoglu MB, Gaffan EA, Ho AK. The Huntington's Disease health-related Quality of Life questionnaire (HDQoL): a disease-specific measure of health-related quality of life. Clin Genet. 2012; 81(2): 117–22.
- Hocaoglu MB, Gaffan EA, Ho AK. Health-related quality of life in Huntington's disease patients: a comparison of proxy assessment and patient self-rating using the disease-specific Huntington's disease health-related quality of life questionnaire (HDQoL). J Neurol. 2012; 259(9): 1793–800.
- Helder DI, Kaptein AA, van Kempen GM, van Houwelingen JC, Roos RA. Impact of Huntington's disease on quality of life. Mov Disord. 2001; 16(2): 325–30.
- Ho AK, Gilbert AS, Mason SL, Goodman AO, Barker RA. Health-related quality of life in Huntington's disease: Which factors matter most?. Mov Disord. 2009; 24(4): 574–8.
- Clay E, De NA, Dorey J, Squitieri F, Aballea S, Martino T, etal. Validation of the first quality-of-life measurement for patients with Huntington's disease: the Huntington Quality of Life Instrument. Int Clin Psychopharmacol. 2012; 27(4): 208–14.
- Toumi M, Tedroff J, Dorey J, Lamure M. The Euro-HDB – the first large European comprehensive study on the socioeconomic burden of Huntington's disease. Clin Genet. 2009; 76(Supp s1): 1–74..
- Clay E, Dorey J, Toumi M, Tedroff J, Squitieri F, De NA, etal. Validation of the Huntington Clinical Self-Reported Instrument (H-CSRI), a clinimetric patient assessed scale for patients with Huntington's disease. Clin Genetics. 2011; 80(Suppl. 1): 38.
- Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord. 1996; 11(2): 136–42.
- Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993; 2(3): 169–80.
- Hurst NP, Jobanputra P, Hunter M, Lambert M, Lochhead A, Brown H. Validity of Euroqol – a generic health status instrument–in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group. Br J Rheumatol. 1994; 33(7): 655–62.
- van Agt HM, Essink-Bot ML, Krabbe PF, Bonsel GJ. Test-retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med. 1994; 39(11): 1537–44.
- Khemiri A, Clay E, Trigo P, Yebenes J, Dorey J, Toumi M. Validation of Spanish version of the Huntington Clinical Self-Reported Instrument (H-CSRI). Val Health. 2012; 15: 7.
- Khemiri A, Clay E, Trigo P, Yebenes J, Toumi M. Cross cultural validation of the Huntington Quality of Life Instrument in Spain (H-QoL-I). Val Health. 2012; 15: 7.
- Williams A. The Measurement and Valuation of Health: Final report on the modelling of valuation tariffs. 1995; York: MVH Group, Centre for Health Economics, University of York.
- Dorey J, Clay E, Aubeeluck A, Verny C, Aballea S, Squitieri F, etal. Quality of life of caregivers in Huntington's disease—First results from Euro-HDB study. Value Health. 2011; 13(7): A395.